Skip to main content
Clinical Trials/ISRCTN30070325
ISRCTN30070325
Completed
未知

A randomized, prospective, pilot study comparing the efficacy of Selective Laser Trabeculoplasty versus Brimonidine tartrate 0.2%/Timolol maleate 0.5% (Combigan, Allergan Inc.) in lowering intraocular pressure as adjunct therapy in Primary Open Angle Glaucoma.

niversity of Pikeville Kentucky College of Optometry0 sites23 target enrollmentDecember 14, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Primary Open Angle Glaucoma
Sponsor
niversity of Pikeville Kentucky College of Optometry
Enrollment
23
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2019 Preprint results in https://doi.org/10.21203/rs.2.473/v1 (added 28/09/2021) 2021 Results article in http://dx.doi.org/10.24966/OCR-8887/100075 (added 28/09/2021)

Registry
who.int
Start Date
December 14, 2018
End Date
July 25, 2018
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Pikeville Kentucky College of Optometry

Eligibility Criteria

Inclusion Criteria

  • 1\. Uncontrolled primary open angle glaucoma
  • 2\. Open angle on gonioscopy
  • 3\. Aged 25 to 90 years
  • 4\. Currently taking a prostaglandin analog, but IOP not controlled with monotherapy

Exclusion Criteria

  • 1\. Best corrected visual acuity worse than 20/40 in the study eye (meaning 20/50 or worse)
  • 2\. Hx of angle closure or an occludable angle on gonioscopy
  • 3\. Untreated IOP less than or equal to 21 mmHg
  • 4\. Patients who have used a second IOP lowering medication in the past 2 months
  • 5\. Angle recession on gonioscopy
  • 6\. Pseudoexfoliation glaucoma
  • 7\. Pigment dispersion glaucoma
  • 8\. Prior incisional glaucoma surgery
  • 9\. Prior Microinvasive Glaucoma Surgery (MIGS, istent, Endocyclophotocoagulation)
  • 10\. Previous SLT or Argon Laser Trabeculoplasty (ALT)

Outcomes

Primary Outcomes

Not specified

Similar Trials